Naslund John A, Marsch Lisa A, McHugo Gregory J, Bartels Stephen J
a The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College , Lebanon , NH , USA .
b The Center for Technology and Behavioral Health, Dartmouth College , Lebanon , NH , USA .
J Ment Health. 2015;24(5):321-32. doi: 10.3109/09638237.2015.1019054. Epub 2015 May 28.
Serious mental illness (SMI) is one of the leading causes of disability worldwide. Emerging mobile health (mHealth) and eHealth interventions may afford opportunities for reaching this at-risk group.
To review the evidence on using emerging mHealth and eHealth technologies among people with SMI.
We searched MEDLINE, PsychINFO, CINAHL, Scopus, Cochrane Central, and Web of Science through July 2014. Only studies which reported outcomes for mHealth or eHealth interventions, defined as remotely delivered using mobile, online, or other devices, targeting people with schizophrenia, schizoaffective disorder, or bipolar disorder, were included.
Forty-six studies spanning 12 countries were included. Interventions were grouped into four categories: (1) illness self-management and relapse prevention; (2) promoting adherence to medications and/or treatment; (3) psychoeducation, supporting recovery, and promoting health and wellness; and (4) symptom monitoring. The interventions were consistently found to be highly feasible and acceptable, though clinical outcomes were variable but offered insight regarding potential effectiveness.
Our findings confirm the feasibility and acceptability of emerging mHealth and eHealth interventions among people with SMI; however, it is not possible to draw conclusions regarding effectiveness. Further rigorous investigation is warranted to establish effectiveness and cost benefit in this population.
严重精神疾病(SMI)是全球致残的主要原因之一。新兴的移动健康(mHealth)和电子健康干预措施可能为接触这一高危人群提供机会。
回顾关于在患有严重精神疾病的人群中使用新兴移动健康和电子健康技术的证据。
我们检索了截至2014年7月的MEDLINE、PsychINFO、CINAHL、Scopus、Cochrane Central和科学引文索引。仅纳入了那些报告移动健康或电子健康干预结果的研究,这些干预被定义为使用移动设备、在线或其他设备远程提供,目标人群为精神分裂症、分裂情感性障碍或双相情感障碍患者。
纳入了来自12个国家的46项研究。干预措施分为四类:(1)疾病自我管理和复发预防;(2)促进药物治疗和/或治疗的依从性;(3)心理教育、支持康复以及促进健康;(4)症状监测。尽管临床结果各不相同,但这些干预措施一直被认为具有高度可行性和可接受性,并且提供了有关潜在有效性的见解。
我们的研究结果证实了新兴移动健康和电子健康干预措施在患有严重精神疾病的人群中的可行性和可接受性;然而,无法就有效性得出结论。有必要进行进一步严格的调查,以确定该人群中的有效性和成本效益。